drugset / Trial / NCT01878669
Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
RandomizedParallel-groupTriple-blindPrevention
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.
Timeline
- Start
- 2013-01
- Primary completion
- 2017-09
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 50 mg/kg | Intravenous |